COCRYSTAL PHARMA, INC. Proceeds from Notes Payable
COCRYSTAL PHARMA, INC. (COCP) reported Proceeds from Notes Payable of $8.61 million for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2013-11-18
- COCRYSTAL PHARMA, INC. proceeds from notes payable for the quarter ending 2013-09-30 was $8.61M.
- COCRYSTAL PHARMA, INC. proceeds from notes payable for the quarter ending 2013-06-30 was $50.00K.
- COCRYSTAL PHARMA, INC. proceeds from notes payable for the quarter ending 2013-03-31 was $6.51M.
- COCRYSTAL PHARMA, INC. proceeds from notes payable for the quarter ending 2012-09-30 was $0.00.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month |
|---|---|---|---|
| 2013-09-30 | $8.61M 10-Q · filed 2013-11-18 | $8.66M derived: sum of 2 quarters · filed 2013-11-18 | $15.16M derived: sum of 3 quarters · filed 2013-11-18 |
| 2013-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-15 | $6.56M 10-Q · filed 2013-08-15 | |
| 2013-03-31 | $6.51M 10-Q · filed 2013-05-10 | ||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $6.51M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $6.51M 10-Q/A · filed 2012-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |